Developing improved molecular biomarkers for early detection, risk stratification and disease monitoring in cancer.
Professor Sarah-Jane Dawson's laboratory aims to develop improved molecular biomarkers for early detection, risk stratification and disease monitoring in cancer.
A major focus of the group's research is the development of non-invasive blood-based biomarkers, to enable personalised disease monitoring and facilitate therapeutic decisions in both solid and haematological malignancies, and thereby improve patient outcomes.
Projects include liquid biopsies for molecular disease monitoring in cancer and understanding the genomic heterogeneity of circulating tumour cells.
Contact and more information
Professor Sarah-Jane Dawson
The Sir Peter MacCallum Department of Oncology